BAYER-3021
Metrika A1cNow InView Test
(20 Dipsosable Cartridges)
Bayer A1CNow+® Multi-Test A1C System, a handheld portable testing monitor provides A1C results at point-of-care. Product is indicated for all physicians’ offices and clinics that manage patients with diabetes. Provides results in 5 minutes so you can have on-the-spot treatment discussion with your diabetes patients face-to-face. Available in 10 & 20 test kit. Each kit contains 1 re-usable monitor, 10 or 20 test cartridges and 10 or 20 sample dilution pouches with instruction. (FOR PROFESSIONAL USE ONLY.) FDA 510K#: K020235

$214.95

Qty:

Insert

Background:

-The A1C value is an index of mean blood glucose over the past two to three months with the majority of that value weighted in the last thirty days. This bias is due to the body's natural destruction and replacement of red blood cells. Because red cells are constantly being destroyed and replaced, it does not take 120 days to detect a clinically meaningful change in A1C following a significant change in mean blood glucose.(10)

Clinical Utility:

-The Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) studies showed that the lower the A1C number, the greater the chances to slow or prevent the development of serious eye, kidney and nerve disease. The studies also showed that any improvement in A1C levels can potentially reduce complications.(8,9)

-The ADA considers the diabetes to be under control when the A1C result is 7 percent or less. The Links and Resources page of this site contains several resources to assist you in managing your patients.(3)